Live Breaking News & Updates on சீனா தேசிய பயோடெக் குழு இணை லிமிடெட்

Stay informed with the latest breaking news from சீனா தேசிய பயோடெக் குழு இணை லிமிடெட் on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in சீனா தேசிய பயோடெக் குழு இணை லிமிடெட் and stay connected to the pulse of your community

Duopharma slumps to 13-month low ahead of EGM

KUALA LUMPUR: Shares of Duopharma Biotech Bhd hit a near 13-month low of RM2.35 on Thursday ahead of its shareholders’ meeting the next day for the proposed bonus issue

Kuala-lumpur , Malaysia , Malaysian , Malaysians , Pharmaniaga-bhd , Sinovac-covid , Equities-research , Malaysia-vaccination-programme , Malaysia-drug-control-authority , Ta-research , China-national-biotec-group-co-ltd , Duopharma-biotech

Vaccine production likely from Oct in country-570344

Vaccine production likely from Oct in country-570344
daily-sun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from daily-sun.com Daily Mail and Mail on Sunday newspapers.

Beijing , China , Bangladesh , Gopalganj , Bangladesh-general- , Dhaka , Chinese , Bangladeshi , Mustafa-kamal , Hasneen-muktadir , Ehsanul-kabir , Khurshid-alam

CGS-CIMB Research retains Add for Duopharma, TP RM3.67

KUALA LUMPUR: CGS-CIMB Equities Research is retaining its Add call for Duopharma
Biotech with an unchanged target price of RM3.67 due to the potential long-term earnings prospects from the development of vaccine manufacturing capabilities, which is a key rerating catalyst.
It said on Monday it was keeping its forecasts intact for now pending the details or further developments in the supply agreement for the Sinopharm vaccine, which it thinks could be signed by end of the month.
“We retain our Add call on the stock with an unchanged TP of RM3.67 based on a CY22F P/E of 28.8 times (+2 standard deviations from its five-year mean),” the research house said.

Kuala-lumpur , Malaysia , Malaysian , Khairy-jamaluddin , Equities-research , Gamaleya-institute-of-russia , Malaysia-drug-control-authority , China-national-biotec-group-co-ltd , Immunisation-programme , World-health-organisation , Pfizer , Astrazeneca

'Health Silk Road 2020: A Bridge to the Future of Health for All'

'Health Silk Road 2020: A Bridge to the Future of Health for All'
chinadaily.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chinadaily.com.cn Daily Mail and Mail on Sunday newspapers.

Malaysia , Japan , Philippines , Dubai , Dubayy , United-arab-emirates , Shanghai , China , Hong-kong , Cainiao , China-general , Shenzhen

'Health Silk Road 2020: A Bridge to the Future of Health for All'

'Health Silk Road 2020: A Bridge to the Future of Health for All'
chinadaily.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chinadaily.com.cn Daily Mail and Mail on Sunday newspapers.

Malaysia , Japan , Philippines , Dubai , Dubayy , United-arab-emirates , Shanghai , China , Hong-kong , Cainiao , China-general- , Shenzhen

China's Sinopharm vaccine: how effective is it and where will it be rolled out?

China's Sinopharm Covid vaccine: how effective is it and where will it be rolled out?
Helen Davidson
© Provided by The Guardian
Photograph: Tingshu Wang/Reuters
Trials in the United Arab Emirates have shown that China’s Sinopharm vaccine has 86% efficacy. So what is the Chinese treatment, where is it being trialled and will it challenge the vaccines being developed in western countries?
© Photograph: Tingshu Wang/Reuters
Sinopharm is a state-owned Chinese pharmaceutical company and is trialling two Covid-19 vaccines in countries including UAe, Argentina and Morocco.
What is the Sinopharm vaccine?
Sinopharm Group is a state-owned pharmaceutical company with two vaccine candidates among China’s five experimental treatment in international final stage trials. The vaccines are not being trialled in China because the domestic prevalence of the virus is so low. Sinopharm’s vaccine and bioscience subsidiary is the China National Biotec Group Co Ltd (CNBG). Public statements about Sinopharm vaccines do not appear to clarify which of the two candidates are being discussed.

Egypt , Argentina , Morocco , China , Peru , United-arab-emirates , Wuhan , Hubei , Bahrain , Peruvian , Chinese , Terry-nolan

China's Sinopharm Covid vaccine: how effective is it and where will it be rolled out?

China's Sinopharm Covid vaccine: how effective is it and where will it be rolled out?
Helen Davidson
© Provided by The Guardian
Photograph: Tingshu Wang/Reuters
Trials in the United Arab Emirates have shown that China’s Sinopharm vaccine has 86% efficacy. So what is the Chinese treatment, where is it being trialled and will it challenge the vaccines being developed in western countries?
© Photograph: Tingshu Wang/Reuters
Sinopharm is a state-owned Chinese pharmaceutical company and is trialling two Covid-19 vaccines in countries including UAe, Argentina and Morocco.
What is the Sinopharm vaccine?
Sinopharm Group is a state-owned pharmaceutical company with two vaccine candidates among China’s five experimental treatment in international final stage trials. The vaccines are not being trialled in China because the domestic prevalence of the virus is so low. Sinopharm’s vaccine and bioscience subsidiary is the China National Biotec Group Co Ltd (CNBG). Public statements about Sinopharm vaccines do not appear to clarify which of the two candidates are being discussed.

Egypt , Argentina , Morocco , China , Peru , United-arab-emirates , Wuhan , Hubei , Bahrain , Peruvian , Chinese , Terry-nolan

US approves Pfizer COVID-19 vaccine, who will be next?

US approves Pfizer COVID-19 vaccine, who will be next?
gulfnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gulfnews.com Daily Mail and Mail on Sunday newspapers.

United-states , Germany , India , Gulf-news , Dubayy , United-arab-emirates , United-kingdom , Brazil , China , Russia , Britain , Chinese